In collaboration with MMV, based in Switzerland, Cipla and Strides Arcolab venture to develop rectal artesunate for pre-referral malaria treatment severe in children. The MMV-led project is UNITAID funded and intend to submit a rectal artesunate product to WHO World Health Organisation. A 5.6 million cases have been estimated for severe malaria every year and results to 627,000 deaths and it includes mostly children under five years. "We have agreed a clear ...
via Medindia Health News More READ
No comments:
Post a Comment